Search - tctmd.com

Displaying 221 - 240 of 407

Sort: Relevancy | Date

News Conference News ISET 2018

Revascularization or Medical Therapy? CREST-2 Aims to Get It Right in Asymptomatic Carotid Disease

Caitlin E. Cox

February 07, 2018

News Daily News

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Caitlin E. Cox

February 05, 2018

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

Presentation TCT 2017

Counterpoint Clinical Trial Results are Inconclusive and Systematic Use of Cerebral Protection During TVR is Unwarranted!

Presenter: Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Point A Balanced Look at ALL the Data Favors Cerebral Protection in ALL TAVR Patients!

Presenter: Saif Anwaruddin

November 01, 2017

Presentation TCT 2017

TCT 108: Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During TAVR

Presenter: Steven R. Bailey, Patrick W. Serruys, Tobias Schmidt, MD

November 01, 2017

Presentation TCT 2017

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine CON!

Presenter: Adrian P. Banning, Ted Feldman, Daniel J. Blackman

November 01, 2017

Presentation TCT 2017

When to Use Cerebral Protection During TAVR

Presenter: Alfredo Trento, Alexandra J. Lansky

November 01, 2017

Presentation TCT 2017

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine - PRO!

Presenter: Adrian P. Banning, Ted Feldman, Eberhard Grube

November 01, 2017

Presentation TCT 2017

Recommendations for Cerebral Protection during TAVR Selective vs. Systematic and Special Circumstances

Presenter: Charles J. Davidson, Mathew Williams, Julia Seeger

November 01, 2017

Presentation TCT 2017

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Presenter: Jochen Wöhrle

October 31, 2017

Presentation TCT 2017

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger

October 31, 2017

Presentation TCT 2017

Taped and Edited Live-Case of the Use of a TriGuard Cerebral Protection Device During TAVR With Sapien 3

Presenter: Francesco Saia, Gerhard C. Schuler, Pieter R. Stella

October 31, 2017

Presentation TCT 2017

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Presenter: Dariusz Dudek, Martin Hudec, Julia Seeger

October 30, 2017

Presentation TCT 2017

Cerebral Protection During TAVR: Routine vs Selective Use

Presenter: David Hildick-Smith, Lars Sondergaard, Axel Linke

October 29, 2017

Manuscript

Cerebral Embolic Protection: Point–Counter Point

September 08, 2017

News Industry News

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

September 05, 2017

Manuscript

Cerebral Embolic Protection: Not Enough Evidence to Support Routine Clinical Use

August 14, 2017

News Daily News

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Michael O'Riordan

August 02, 2017

News Industry News

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

August 01, 2017

Advertisement

Revascularization or Medical Therapy? CREST-2 Aims to Get It Right in Asymptomatic Carotid Disease

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Counterpoint Clinical Trial Results are Inconclusive and Systematic Use of Cerebral Protection During TVR is Unwarranted!

Point A Balanced Look at ALL the Data Favors Cerebral Protection in ALL TAVR Patients!

TCT 108: Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During TAVR

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine CON!

When to Use Cerebral Protection During TAVR

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine - PRO!

Recommendations for Cerebral Protection during TAVR Selective vs. Systematic and Special Circumstances

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Taped and Edited Live-Case of the Use of a TriGuard Cerebral Protection Device During TAVR With Sapien 3

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Cerebral Protection During TAVR: Routine vs Selective Use

Cerebral Embolic Protection: Point–Counter Point

Protembis announces successful first-in-human use of its ProtEmbo® Cerebral Protection System in European trial

Cerebral Embolic Protection: Not Enough Evidence to Support Routine Clinical Use

Many Stroke Patients Stop Statins or Never Start, With Dire Consequences

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content